XML 17 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Statements of Changes in Stockholders' Deficit - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Apr. 30, 2023
Balance, shares at Apr. 30, 2023      
Remeasurement of common stock subject to possible redemption (631,524) (631,524)
Net income 535,209 535,209
Founder shares issued to initial stockholders $ 172 24,828 25,000
Founder shares issued to initial stockholders, shares 1,725,000      
Proceeds from sale of IPO Units $ 690 68,999,310 69,000,000
Proceeds from sale of IPO Units, shares 6,900,000      
Proceeds from sale of Private Placement Units $ 25 2,530,425 2,530,450
Proceeds from sale of Private Placement Units, shares 253,045      
Issuance of representative shares $ 7 (7)
Issuance of representative shares, shares 69,000      
Common stock subject to possible redemption $ (690) (69,689,310) (69,690,000)
Common stock subject to possible redemption, shares (6,900,000)      
Underwriter commissions (2,415,000) (2,415,000)
Offering costs (1,097,729) (1,097,729)
Accretion of additional paid in capital to accumulated deficit 1,647,476 (1,647,476)
Balance at Dec. 31, 2023 $ 204 (1,743,798) (1,743,594)
Balance, shares at Dec. 31, 2023 2,047,045      
Remeasurement of common stock subject to possible redemption (2,816,434) (2,816,434)
Net income 2,094,096 2,094,096
Balance at Dec. 31, 2024 $ 204 $ (2,466,136) $ (2,465,932)
Balance, shares at Dec. 31, 2024 2,047,045